Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2–encoded ORF8 protein possesses complement inhibitory properties
Jitendra Kumar, Saurabh Dhyani, Prateek Kumar, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 3, pp. 102930-102930
Open Access | Times Cited: 17

Showing 17 citing articles:

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
Wioleta M. Zelek, R. A. Harrison
Immunobiology (2023) Vol. 228, Iss. 3, pp. 152393-152393
Open Access | Times Cited: 27
SARS-CoV-2 ORF8: A Rapidly Evolving Immune and Viral Modulator in COVID-19
Ariana Arduini, Frederique Laprise, Chen Liang
Viruses (2023) Vol. 15, Iss. 4, pp. 871-871
Open Access | Times Cited: 23
Emerging role of complement in COVID-19 and other respiratory virus diseases
Mark Xiao, Calder Ellsworth, Xuebin Qin
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 8
SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
Marília Inês Móvio, Giovana Waner Carneiro de Almeida, Isabella das Graças Lopes Martines, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 161-161
Open Access | Times Cited: 6
Enhanced complement activation and MAC formation accelerates severe COVID-19
Calder Ellsworth, Zhen Chen, Mark Xiao, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins
María Guadalupe Vizoso-Pinto, Leonardo de Paula Pereira, Ana Luiza Pessoa de Mendonça Angelo, et al.
Journal of Molecular Recognition (2025) Vol. 38, Iss. 2
Closed Access
Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response
Marija Janevska, Evelien Naessens, Bruno Verhasselt
Viruses (2025) Vol. 17, Iss. 4, pp. 569-569
Open Access
Beyond Infection: The Role of Secreted Viral Proteins in Pathogenesis, Disease Severity and Diagnostic Applications
Luis Herrera-Moro Huitron, Víctor Javier Cruz-Holguín, José Manuel Ulloa-Aguilar, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 624-624
Open Access
A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Karel Van Damme, Levi Hoste, Jozefien Declercq, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 710
Open Access | Times Cited: 9
The complement system: A key player in the host response to infections
Archana Jayaraman, Sarah Walachowski, Markus Bosmann
European Journal of Immunology (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 3
Polyvalency: an emerging trend in the development of clinical antibodies
Suraj H. Shinde, Sandeep Sherawat, Abhay H. Pande
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103846-103846
Closed Access | Times Cited: 6
Ligands docking to ORF8 by co-evolution. Could they reduce the inflammation levels induced by SARS-COV-2 infections?
Melissa Belló-Pérez, Julio Coll
(2023)
Open Access | Times Cited: 4
Transplacental SARS-CoV-2 protein ORF8 binds to complement C1q to trigger fetal inflammation
Tamiris Azamor, Débora Familiar-Macedo, Gielenny M. Salem, et al.
The EMBO Journal (2024) Vol. 43, Iss. 22, pp. 5494-5529
Closed Access
Nanomedicine’s Role in the COVID-19 Vaccine Development and Optimization
Jitendra Kumar, Jaya Malhotra, Amit Singh Yadav, et al.
Nanotechnology in the life sciences (2024), pp. 39-57
Closed Access
Oligomer formation of SARS-CoV-2 ORF8 through 73YIDI76 motifs regulates immune response and non-infusion antiviral interactions
Mohammad Assadizadeh, Maryam Azimzadeh Irani
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 1
SARS‐COV‐2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
Marília Inês Móvio, Giovana Carneiro, Isabella Lopes Martines, et al.
(2023)
Open Access | Times Cited: 1
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
Karel Van Damme, Levi Hoste, Jozefien Declercq, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Co-evolved ligands to ORF8. Could they reduce SARS-COV-2-excesive inflammation?
Melissa Belló-Pérez, Julio Coll
(2023)
Open Access
Page 1

Scroll to top